KennethBruceAinMD(He/Him)
Endocrinology • Lexington, KYThyroid
Founder and former Director, Thyroid Oncology Program
Dr. Ain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2336 Abbeywood Rd
Lexington, KY 40515Phone+1 859-806-3035Fax+1 859-806-3035- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1987
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1981 - 1984
The Warren Alpert Medical School of Brown UniversityClass of 1981
Certifications & Licensure
KY State Medical License 1990 - 2025
MD State Medical License 1987 - 1992
PA State Medical License 1982 - 1992
IL State Medical License 1984 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
Clinical Trials
- Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer Start of enrollment: 1999 Jul 01
- Thalidomide in Treating Patients With Thyroid Cancer Start of enrollment: 2001 Jun 01
- REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas Start of enrollment: 2006 Feb 01
Publications & Presentations
PubMed
- 194 citations2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer: American Thyroid Association Anaplastic Thyroid Cancer Guidelin...Brito, J. P., Brito, J. P., Brito, J. P., Brito, J. P., Keith C. Bible, Electron Kebebew, James Brierley, Juan P. Brito, Maria E. Cabanillas, Thomas J. Clark, Antonio ...> ;Thyroid. 2021 Mar 1
- 8 citationsAssociation of Radioactive Iodine Treatment of Hyperthyroidism With Cancer Mortality: An Unjustified Warning?Elif Hindié, Kenneth B. Ain, Slimane Zerdoud, Anca M. Avram> ;The Journal of Clinical Endocrinology and Metabolism. 2020 Apr 1
- 15 citationsReassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at DiagnosisDonald S. A. McLeod, Jacqueline Jonklaas, James D. Brierley, Kenneth B. Ain, David S. Cooper, Henry G. Fein, Bryan R. Haugen, Paul W. Ladenson, James Magner, Douglas S...> ;Thyroid. 2015 Sep 24
- Join now to see all
Press Mentions
Hypothyroidism May Lead to Impaired DrivingJune 23rd, 2014
Grant Support
- Transcriptional Repression Of Sodium-Iodide Symporter In Thyroid CarcinomaNational Cancer Institute2008–2011
- Phase II Trial Of ThalidimideNational Center For Research Resources2004
- Demethylation Therapy Of Thyroid CarcinomaNational Cancer Institute2000–2004
- Restoration Of Radioiodine Uptake In Thyroid CarcinomaNational Center For Research Resources2000–2002
- Restoration Of Radioiodine Uptake In Thyroid Carcinoma--Clinical TrialNational Center For Research Resources1998–1999
- Thyroid Carcinoma Inhibition By SomatostatinNational Cancer Institute1994–1998
Professional Memberships
- Member
- Member
- Endocrine Ethics AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
